Your session is about to expire
← Back to Search
Milk Thistle for Body Dysmorphic Disorder
Study Summary
This trial will study the effects of milk thistle on 15 people, divided into two 4-week phases with a one-week break in between. One phase will have the participants taking milk thistle, and the other phase will have them taking a placebo. The trial will be double-blind, meaning neither the participants nor the researchers will know which group is taking the milk thistle until the trial is over.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2020 Phase 2 trial • 22 Patients • NCT02473913Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the participant capacity for this research endeavor?
"Affirmative, clinicaltrials.gov displays that this investigation is actively recruiting candidates. Initially advertised on October 1st 2016, the trial necessitates 15 participants to be recruited at one location."
Is this particular trial the inaugural study of its type?
"Currently, two trials for milk thistle are ongoing in multiple cities and countries. The first experiment took place in 2009, sponsored by Madaus Inc., with 140 participants making it through Phase 2 & 3 of the drug approval process. Since then, 18337 studies have been conducted."
Who can participate in this clinical trial?
"Only those with body dysmorphic disorder and aged between 18-65 are eligible to participate in this research. 15 individuals need to be enrolled into the study."
Does this trial currently have open enrollment?
"Per the information on clinicaltrials.gov, this trial is proactively seeking volunteers. The original posting was made on October 1st 2016 and the entry has since been updated November 2nd 2022."
Has the FDA sanctioned Milk Thistle for medical use?
"Milk thistle has only been through two rounds of clinical testing, suggesting that the safety level is approximately a 2. Unfortunately, there is not yet any evidence to indicate its efficacy."
Does this trial permit those aged eighty-five and above to participate?
"This clinical trial has an age requirement of 18 to 65, whereas there are 4 separate trials for those younger and 8 for those older."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger